BloodSTAR

BloodSTAR (Blood System for Tracking Authorisations and Reviews) is a new ICT system currently under development by the National Blood Authority. The system will standardise and manage access to the supply of immunoglobulin products for the treatment of conditions identified in the Criteria for the clinical use of intravenous immunoglobulin in Australia, funded by all governments through the national blood arrangements.

 

Bloodstar Go Live table

 

National Blood Authority from Next In Line Films on Vimeo.

Latest online version of the Criteria

An adaptation of the second edition of the Criteria is applicable in BloodSTAR from its launch in July 2016. The Criteria as they appear in BloodSTAR can be viewed here.

During the BloodSTAR transition period, the addition of ‘new’ Criteria ‘evidence items’ fields does not change the basis for approval of authorisation of Ig product. Authorisers will evaluate authorisation requests with the same approach that applies to authorisation based on the use of previous paper forms. 

Moving or Travelling Patient Process during BloodSTAR Transition

For guidance when patients receiving immunoglobulin products travel or move between States and/or Territories where BloodSTAR may or may not have been implemented, please refer to the below document.

BloodSTAR and BloodNet Downtime Process

Details in the documents below on the steps to undertake if BloodSTAR or BloodNet are unavailable

What is BloodSTAR? Flyer

Please distribute the flyer below via email, or print and display in your workplace for the information of your colleagues

    Further Information

    ​Definitions (34.66 KB) Definitions (124.98 KB)

    To discuss BloodSTAR further, please don’t hesitate to contact the Blood Operations Centre on 13 000 BLOOD (13 000 25663) or support [at] blood.gov.au .